Endodermal sinus tumor

WikiDoc Resources for Endodermal sinus tumor
Articles
Most recent articles on Endodermal sinus tumor Most cited articles on Endodermal sinus tumor Review articles on Endodermal sinus tumor Articles on Endodermal sinus tumor in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Endodermal sinus tumor Images of Endodermal sinus tumor Photos of Endodermal sinus tumor Podcasts & MP3s on Endodermal sinus tumor Videos on Endodermal sinus tumor
Evidence Based Medicine
Cochrane Collaboration on Endodermal sinus tumor Bandolier on Endodermal sinus tumor TRIP on Endodermal sinus tumor
Clinical Trials
Ongoing Trials on Endodermal sinus tumor at Clinical Trials.gov Trial results on Endodermal sinus tumor Clinical Trials on Endodermal sinus tumor at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Endodermal sinus tumor NICE Guidance on Endodermal sinus tumor NHS PRODIGY Guidance FDA on Endodermal sinus tumor CDC on Endodermal sinus tumor
Books
Books on Endodermal sinus tumor
News
Endodermal sinus tumor in the news Be alerted to news on Endodermal sinus tumor News trends on Endodermal sinus tumor
Commentary
Blogs on Endodermal sinus tumor
Definitions
Definitions of Endodermal sinus tumor
Patient Resources / Community
Patient resources on Endodermal sinus tumor Discussion groups on Endodermal sinus tumor Patient Handouts on Endodermal sinus tumor Directions to Hospitals Treating Endodermal sinus tumor Risk calculators and risk factors for Endodermal sinus tumor
Healthcare Provider Resources
Symptoms of Endodermal sinus tumor Causes & Risk Factors for Endodermal sinus tumor Diagnostic studies for Endodermal sinus tumor Treatment of Endodermal sinus tumor
Continuing Medical Education (CME)
CME Programs on Endodermal sinus tumor
International
Endodermal sinus tumor en Espanol Endodermal sinus tumor en Francais
Business
Endodermal sinus tumor in the Marketplace Patents on Endodermal sinus tumor
Experimental / Informatics
List of terms related to Endodermal sinus tumor

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Monalisa Dmello, M.B,B.S., M.D. [2]; Shivali Marketkar, M.B.B.S. [3]; Ammu Susheela, M.D. [4]

Synonyms and keywords: EST

Historical Perspective

• [Disease name] was first discovered by [scientist name], a [nationality + occupation], in [year] during/following [event].
• In [year], [gene] mutations were first identified in the pathogenesis of [disease name].
• In [year], the first [discovery] was developed by [scientist] to treat/diagnose [disease name].

Classification

• Endodermal sinus tumor may be classified according to histology into 10 groups:

• Reticular
• Endodermal sinus-like
• Microcystic
• Papillary
• Solid
• Glandular
• Alveolar
• Polyvesicular vitelline
• Enteric
• Hepatoid

Pathophysiology

• The pathogenesis of [disease name] is characterized by [feature1], [feature2], and [feature3].
• The [gene name] gene/Mutation in [gene name] has been associated with the development of [disease name], involving the [molecular pathway] pathway.
• On gross pathology, [feature1], [feature2], and [feature3] are characteristic findings of [disease name].
• On microscopic histopathological analysis, [feature1], [feature2], and [feature3] are characteristic findings of [disease name].

Causes

• [Disease name] may be caused by either [cause1], [cause2], or [cause3].
• [Disease name] is caused by a mutation in the [gene1], [gene2], or [gene3] gene[s].
• There are no established causes for [disease name].

Differentiating From Endodermal sinus tumor Other Diseases

Endodermal sinus tumor must be differentiated from other diseases that cause ovarian mass, such as stein-Leventhal syndrome, ovary teratoma, tubal pregnancy, ovary adenocarcinoma, and tubo-ovarian abscess.

Epidemiology and Demographics

• The prevalence of [disease name] is approximately [number or range] per 100,000 individuals worldwide.
• In [year], the incidence of [disease name] was estimated to be [number or range] cases per 100,000 individuals in [location].

Age

• Patients of all age groups may develop [disease name].
• [Disease name] is more commonly observed among patients aged [age range] years old.
• [Disease name] is more commonly observed among [elderly patients/young patients/children].

Gender

• [Disease name] affects men and women equally.
• [Gender 1] are more commonly affected with [disease name] than [gender 2].
• The [gender 1] to [Gender 2] ratio is approximately [number > 1] to 1.

Race

• There is no racial predilection for [disease name].
• [Disease name] usually affects individuals of the [race 1] race.
• [Race 2] individuals are less likely to develop [disease name].

Risk Factors

• Common risk factors in the development of [disease name] are [risk factor 1], [risk factor 2], [risk factor 3], and [risk factor 4].

Natural History, Complications and Prognosis

• The majority of patients with [disease name] remain asymptomatic for [duration/years].
• Early clinical features include [manifestation 1], [manifestation 2], and [manifestation 3].
• If left untreated, [#%] of patients with [disease name] may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].
• Common complications of [disease name] include [complication 1], [complication 2], and [complication 3].
• Prognosis is generally [excellent/good/poor], and the [1/5/10year mortality/survival rate] of patients with [disease name] is approximately [#%].

Diagnosis

Diagnostic Criteria

• The diagnosis of [disease name] is made when at least [number] of the following [number] diagnostic criteria are met:

• [criterion 1]
• [criterion 2]
• [criterion 3]
• [criterion 4]

Symptoms

The symptoms of endodermal sinus tumor include the following:

• Abdominal distention
• Acute/sub acute abdominal pain

Physical Examination

Ovarian Germ Cell Tumor Physical Examination

Abdomen

• Abdominal distention
• Abdominal tenderness

Pelvic exam

• Adnexal mass

Laboratory Findings

• There are no specific laboratory findings associated with [disease name].
• A [positive/negative] [test name] is diagnostic of [disease name].
• An [elevated/reduced] concentration of [serum/blood/urinary/CSF/other] [lab test] is diagnostic of [disease name].
• Other laboratory findings consistent with the diagnosis of [disease name] include [abnormal test 1], [abnormal test 2], and [abnormal test 3].

Imaging Findings

• There are no [imaging study] findings associated with [disease name].
• [Imaging study 1] is the imaging modality of choice for [disease name].
• On [imaging study 1], [disease name] is characterized by [finding 1], [finding 2], and [finding 3].
• [Imaging study 2] may demonstrate [finding 1], [finding 2], and [finding 3].

Other Diagnostic Studies

• [Disease name] may also be diagnosed using [diagnostic study name].
• Findings on [diagnostic study name] include [finding 1], [finding 2], and [finding 3].

Treatment

Medical Therapy

• There is no treatment for [disease name]; the mainstay of therapy is supportive care.
• The mainstay of therapy for [disease name] is [medical therapy 1] and [medical therapy 2].
• [Medical therapy 1] acts by [mechanism of action1].
• Response to [medical therapy 1] can be monitored with [test/physical finding/imaging] every [frequency/duration].

Surgery

• Surgery is the mainstay of therapy for [disease name].
• [Surgical procedure] in conjunction with [chemotherapy/radiation] is the most common approach to the treatment of [disease name].
• [Surgical procedure] can only be performed for patients with [disease stage] [disease name].

Prevention

• There are no primary preventive measures available for [disease name].
• Effective measures for the primary prevention of [disease name] include [measure1], [measure2], and [measure3].
• Once diagnosed and successfully treated, patients with [disease name] are followedup every [duration]. Followup testing includes [test 1],[test 2], and [test 3].